Twist Bioscience (TWST) Current Assets (2018 - 2026)

Twist Bioscience (TWST) has reported Current Assets for 9 consecutive years, with $321.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Assets fell 5.44% year-over-year to $321.3 million in Q2 2026; TTM through Jun 2026 was $321.3 million, a 5.44% decrease from a year earlier, with the FY2025 full-year figure at $333.0 million, down 3.98% from the prior year.
• Current Assets was $321.3 million for Q2 2026 at Twist Bioscience, down from $323.4 million in the prior quarter.
• Over five years, Current Assets peaked at $664.4 million in Q1 2022 and troughed at $303.9 million in Q4 2025.
• A 5-year average of $420.1 million and a median of $366.8 million in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets jumped 40.74% in 2022 and decreased 28.87% in 2023, its largest moves.
• Over 5 years, Current Assets stood at $541.9 million in 2022, then retreated by 27.98% to $390.2 million in 2023, then slipped by 11.51% to $345.3 million in 2024, then slipped by 12.0% to $303.9 million in 2025, then rose by 5.73% to $321.3 million in 2026.
• The last three Current Assets figures came in at $321.3 million (Q2 2026), $323.4 million (Q1 2026), and $303.9 million (Q4 2025), per Business Quant data.